Literature DB >> 16969113

The positive regulation of p53 by the tumor suppressor VHL.

Jae-Seok Roe1, Hong-Duk Youn.   

Abstract

The ubiquitin-mediated degradation of hypoxia-inducible factor-alpha (HIF-alpha) by a von Hippel-Lindau tumor suppressor protein (pVHL) is mechanistically responsible for controlling gene expression due to oxygen availability. Germline mutations in the VHL gene cause dysregulation of HIF and induce an autosomal dominant cancer syndrome referred to as VHL disease. However, it is unclear whether HIF accumulation caused by VHL mutations is sufficient for tumorigenesis. Recently, we found that pVHL directly associates and positively regulates the tumor suppressor p53 by inhibiting Mdm2-mediated ubiquitination, and by subsequently recruiting p53-modifying enzymes. Moreover, VHL-deleted RCC cells showed attenuated apoptosis or abnormal cell-cycle arrest upon DNA damage, but became normal when pVHL was restored. Thus, pVHL appears to play a pivotal role in tumor suppression by participating actively as a component of p53 transactivation complex during DNA damage response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969113     DOI: 10.4161/cc.5.18.3247

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  24 in total

1.  pVHL-mediated transcriptional repression of c-Myc by recruitment of histone deacetylases.

Authors:  In-Young Hwang; Jae-Seok Roe; Ja-Hwan Seol; Hwa-Ryeon Kim; Eun-Jung Cho; Hong-Duk Youn
Journal:  Mol Cells       Date:  2012-02       Impact factor: 5.034

2.  Drosophila VHL tumor-suppressor gene regulates epithelial morphogenesis by promoting microtubule and aPKC stability.

Authors:  Serena Duchi; Luca Fagnocchi; Valeria Cavaliere; Anita Hsouna; Giuseppe Gargiulo; Tien Hsu
Journal:  Development       Date:  2010-05       Impact factor: 6.868

Review 3.  Role of VHL gene mutation in human renal cell carcinoma.

Authors:  Wani Arjumand; Sarwat Sultana
Journal:  Tumour Biol       Date:  2011-11-29

4.  Dual loss of rb1 and Trp53 in the adrenal medulla leads to spontaneous pheochromocytoma.

Authors:  Ian D Tonks; Arne W Mould; Wayne A Schroder; Andrew Cotterill; Nicholas K Hayward; Graeme J Walker; Graham F Kay
Journal:  Neoplasia       Date:  2010-03       Impact factor: 5.715

5.  Drosophila von Hippel-Lindau tumor suppressor gene function in epithelial tubule morphogenesis.

Authors:  Anita Hsouna; Gouthami Nallamothu; Nurgun Kose; Maria Guinea; Vincent Dammai; Tien Hsu
Journal:  Mol Cell Biol       Date:  2010-06-01       Impact factor: 4.272

6.  Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension.

Authors:  Ziyi Wang; Kai Yang; Qiuyu Zheng; Chenting Zhang; Haiyang Tang; Aleksandra Babicheva; Qian Jiang; Meichan Li; Yuqin Chen; Shane G Carr; Kang Wu; Qian Zhang; Angela Balistrieri; Christina Wang; Shanshan Song; Ramon J Ayon; Ankit A Desai; Stephen M Black; Joe G N Garcia; Ayako Makino; Jason X-J Yuan; Wenju Lu; Jian Wang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-25       Impact factor: 5.464

Review 7.  Building it up and taking it down: the regulation of vertebrate ciliogenesis.

Authors:  Nicole Santos; Jeremy F Reiter
Journal:  Dev Dyn       Date:  2008-08       Impact factor: 3.780

8.  The absence of Ser389 phosphorylation in p53 affects the basal gene expression level of many p53-dependent genes and alters the biphasic response to UV exposure in mouse embryonic fibroblasts.

Authors:  Wendy Bruins; Oskar Bruning; Martijs J Jonker; Edwin Zwart; Tessa V van der Hoeven; Jeroen L A Pennings; Han Rauwerda; Annemieke de Vries; Timo M Breit
Journal:  Mol Cell Biol       Date:  2008-01-14       Impact factor: 4.272

9.  Interaction between Nm23 and the tumor suppressor VHL.

Authors:  Chih-Hung Lin; Vincent Dammai; Boris Adryan; Tien Hsu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-06-12       Impact factor: 3.000

10.  Altered PTEN, ATRX, CHGA, CHGB, and TP53 expression are associated with aggressive VHL-associated pancreatic neuroendocrine tumors.

Authors:  Allison B Weisbrod; Lisa Zhang; Meenu Jain; Stephanie Barak; Martha M Quezado; Electron Kebebew
Journal:  Horm Cancer       Date:  2013-01-30       Impact factor: 3.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.